TNF and inflammatory bowel disease: The fact that about one third of patients do not response to these agents [205] emphasizes the importance of understanding molecular mechanisms behind TNF inhibition, which might enable us to categorize IBD patients by predictive response markers and, accordingly, provide them with the most effective treatments.